Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.043 | 0.7 |
mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.7 |
mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.8 |
mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |